Skip to content
Directory

Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
16
currently held
Exits tracked
21
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital
Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital
Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital
Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin
Lauxera Capital Partners1 month ago

Board change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board

admin
Ardian1 month ago

Chairman update · Chairman update: du conseil de surveillance Thomas, Patrick · Chairman information updated

admin
PharmaItaly
25 companies matching
Neopharmed Gentili
NB Renaissance Fund III
Italy
Active
Sector
Pharma
InvestorRenaissance Partners
Entry
2018
Hold
7yr
Owners
3
DMX Pharma
Fondo Italiano Private Equity Co-Investimenti (FIPEC)
Italy
Active
Sector
Pharma
InvestorFondo Italiano d'Investimento SGR
Entry
2022
Hold
3yr
Owners
2
Sifi
21 Investimenti II
Italy
Exited
Sector
Pharma
Investor21 Invest
Entry
2010
Hold
15yr
Exit
2025
to Faes Farma
Content Group
Aksia Capital IV
Italy
Exited
Sector
Pharma
InvestorAksia SGR
Entry
2016
Hold
8yr
Exit
2024
to De Agostini
Archimica
Archimica
LIVIA Corporate Development
Italy
Exited
Sector
Pharma
InvestorLIVIA Group
Entry
2019
Hold
4yr
Exit
2023
to PI HealthSciences
Labomar
Charterhouse Capital Partners XI
Italy
Active
Sector
Pharma
InvestorCharterhouse Capital Partners
Entry
2020
Hold
3yr
Owners
2
1.7x
Kedrion
Permira VII
Italy
Active
Sector
Pharma
InvestorPermira
Entry
2003
Hold
10yr
Owners
4
DOC Generici (ICG)
TPG Europe Portfolio
Italy
Active
Sector
Pharma
InvestorTPG Europe
Entry
2019
Hold
4yr
Owners
2
Mipharm
Alto Capital V
Italy
Active
Sector
Pharma
InvestorAlto Partners SGR
Entry
2016
Hold
6yr
Owners
2
OFI
Alto Capital IV
Italy
Exited
Sector
Pharma
InvestorAlto Partners SGR
Entry
2019
Hold
1yr
Exit
2020
to Farmaceutici Procemsa
Lisapharma
Arcadia Small Cap I
Italy
Exited
Sector
Pharma
InvestorArcadia SGR
Entry
2015
Hold
4yr
Exit
2019
to Shandong Sito Bio-Technology
Italchimici
Italchimici
Progressio Investimenti II
Italy
Exited
Sector
Pharma
InvestorProgressio SGR
Entry
2015
Hold
1yr
Owners
2
Exit
2016
to Recordati3.0x
Euticals
Private Equity Partners Fund IV
Italy
Exited
Sector
Pharma
InvestorPrivate Equity Partners
Entry
2008
Hold
4yr
Owners
3
Exit
2016
to AMRI
Omega Pharma
21 Invest Italy IV
Italy
Active
Sector
Pharma
Investor21 Invest
Entry
2011
Hold
4yr
Owners
2
TREI
IPEF IV Italy
Italy
Exited
Sector
Pharma
InvestorSynergo Capital SGR
Entry
2004
Hold
10yr
Exit
2014
to aniMedica
Bouty Healthcare
Kairos Partners Private Equity Fund
Italy
Exited
Sector
Pharma
InvestorConsilium SGR
Entry
2003
Hold
6yr
Exit
2009
to IBSA
Aileens Pharma
Aileens Pharma
Panakes Fund I
Italy
Active
Sector
Pharma
InvestorPanakes Partners SGR
Entry
2018
Hold
8yr
BMG Pharma
BMG Pharma
Friulia Balance Sheet
Italy
Active
Sector
Pharma
InvestorFriulia
Entry
2021
Hold
5yr
CSO Pharmitalia
CSO Pharmitalia
Star III Private Equity Fund
Italy
Active
Sector
Pharma
InvestorStar Capital SGR
Entry
2016
Hold
10yr
NTC
NTC
Wisequity V
Italy
Active
Sector
Pharma
InvestorWise Equity SGR
Entry
2022
Hold
4yr
Revi Pharma
Revi Pharma
Italian Fine Food
Italy
Active
Sector
Pharma
InvestorAVM SGR
Entry
2026
Hold
0yr
Trifarma
Trifarma
Principia III - Health
Italy
Active
Sector
Pharma
InvestorPrincipia SGR
Entry
2017
Hold
9yr
Genetic
Fondo Italiano Private Equity Co-Investimenti (FIPEC)
Italy
Active
Sector
Pharma
InvestorFondo Italiano d'Investimento SGR
Entry
2025
Hold
1yr
Owners
3
Biofarma Group
Ardian Buyout Fund VII
Italy
Active
Sector
Pharma
InvestorArdian
Entry
2022
Hold
4yr
PharmEste
Principia Fund
Italy
Active
Sector
Pharma
InvestorPrincipia SGR
Entry
2007
Hold
19yr